Pharmacotherapies for Central Post-Stroke Pain: A Systematic Review and Network Meta-Analysis

Figure 2

Risk of bias assessment. Footnotes: The risk of bias was assessed by using the revised Cochrane Risk of Bias tool (RoB 2.0). Five domains of each RCT were assessed and classified into low RoB, some concerns, or high RoB, and an overall assessment was therefore provided after the assessment of the five domains.